A Study of Gimatecan (ST1481) in Small Cell Lung Cancer

NCT04501029 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: Gimatecan

Sponsor

Lee's Pharmaceutical Limited